Association Between Maternal Midterm eGFR and Newborn Birthweight
Kidney360 · 2025
DOI: 10.34067/kid.0000001042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, 2025. Verfasst von Akiko Sankoda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Preconception Care Center, Integrated Center for Women's Health, National Center for Child Health and Development, Tokyo, Japan. Hauptthemen laut MEDLINE: Infant, Low Birth Weight, Glomerular Filtration Rate, Birth Weight. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Ministry of Health, Labor and Welfare, the Japan Agency for Medical Research and Development, the Research Development Grant for Child Health and Development.
Abstract (Originalsprache)
Background
Little is known regarding whether renal function during pregnancy among healthy women is associated with pregnancy outcomes. Evidence based on the universal screening of maternal eGFR is lacking. We investigated the association of maternal eGFR during the second trimester with fetal birthweight.
Methods
This prospective birth cohort study includes 1,666 singleton pregnant women (median age 36 years, median BMI 20.0) who had universal screening of eGFR during the second trimester. Participants were categorized into the quartile of eGFR. The 1 st quartile group was defined as low eGFR, the 4 th quartile group as high eGFR, and the 2 nd and 3 rd quartile group as reference. The primary outcomes are low birthweight (LBW) and small for gestational age (SGA). Multivariable logistic regression models were used to investigate the association of maternal eGFR and pregnancy outcomes.
Results
As compared to the reference group, the adjusted odds ratios (95% Confidence Intervals [CI]) for LBW and SGA in the low eGFR group were 2.25 (1.48-3.40) and 2.51 (1.63-3.87), respectively, and in the high eGFR group were 0.69 (0.40-1.19) and 0.55 (0.30-1.02), respectively. The adjusted odds ratios of eGFR per SD decrease (95% CI) for LBW and SGA were 1.92 (1.50-2.45) (p=0.013) and 2.07 (1.60-2.68) (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Preconception Care Center, Integrated Center for Women's Health, National Center for Child Health and Development, Tokyo, Japan.
- Women's Internal Medicine, Women's Health Center, National Center for Child Health and Development, Tokyo, Japan.
- Department of General Medicine, Juntendo University School of Medicine, Tokyo, Japan.
- Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
- Department of Social Medicine, National Research Institute for Child Health and Development, Tokyo, Japan.
- Division of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo, Japan.
ORCID-Profile: Naoko Arata, Kohei Ogawa, Seiji Wada, Naho Morisaki, Haruhiko Sago
Förderung
- the Ministry of Health, Labor and Welfare
- the Japan Agency for Medical Research and Development
- the Research Development Grant for Child Health and Development
- Japan Science and Technology Agency Grant
Zitieren
APA
Sankoda, A., Arata, N., Yano, Y., Ogawa, K., Umehara, N., Mito, A., Wada, S., Morisaki, N., Ito, Y., Sago, H., & Horikawa, R. (2025). Association Between Maternal Midterm eGFR and Newborn Birthweight. Kidney360. https://doi.org/10.34067/kid.0000001042
Vancouver
Sankoda A, Arata N, Yano Y, Ogawa K, Umehara N, Mito A, et al. Association Between Maternal Midterm eGFR and Newborn Birthweight. Kidney360. 2025. doi:10.34067/kid.0000001042
BibTeX
@article{Sankoda2025,
author = {Sankoda, Akiko and Arata, Naoko and Yano, Yuichiro and Ogawa, Kohei and Umehara, Nagayoshi and Mito, Asako and Wada, Seiji and Morisaki, Naho and Ito, Yushi and Sago, Haruhiko and Horikawa, Reiko},
title = {Association Between Maternal Midterm eGFR and Newborn Birthweight},
journal = {Kidney360},
year = {2025},
doi = {10.34067/kid.0000001042}
}
EUVIMED